Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytomegalovirus Vaccine
Passive immunization decreases risk of congenital cytomegalovirus
November 24th, 2005
Passive immunization during pregnancy decreases the risk of congenital cytomegalovirus infection. According to recent research published in the New England Journal of Medicine, "Currently, there is no effective intervention for a primary cytomegalovirus (CMV) infection during pregnancy. We studied pregnant women with a primary CMV infection. The therapy group comprised women whose amniotic fluid contained either CMV or CMV DNA and who were offered intravenous CMV hyperimmune globulin at a dose of 200 U/kg maternal weight. A prevention group, consisting of women with a recent primary infection before 21 weeks' gestation or who declined amniocentesis, was offered...
Source: Women's Health Weekly (2005-11-24)
|
